A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

NCT05009069 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Neoplasms
Rectal Cancer

Interventions

RADIATION: Radiotherapy
DRUG: Capecitabine
DRUG: Fluorouracil
DRUG: Atezolizumab
DRUG: Tiragolumab

Sponsor

Hoffmann-La Roche